Tandemrepeat
Philadelphia, US · 1 known investors
Tandem Repeat develops Squitex, a biobased fiber material derived from squid ring teeth protein using genetic sequencing tools, intended as an alternative to petroleum-based fibers for the textile industry. The company applies biomimetic design to create durable, more sustainable textile materials.
BiotechCircular EconomyClimate TechNew Materials
Founders & leadership
MD
Melik DemirelFounder
GH
Gozde Hatice Senel-AyazNamed on SEC filing
BA
Benjamin Allen
GS
Gozde Senel-Ayaz
Investors · 1
.jpeg){kind=logo}
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 1 round · 2022
▶$2.2MraisedNov 2022 · 8 investors · Other TechnologyRule 506(b)
▶$2.2MraisedNov 2022 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Melik DemirelDirector
- Gozde Hatice Senel-AyazExecutive Officer, Director
- Amount sold
- $2.2M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Tandemrepeat do?
- Tandem Repeat develops Squitex, a biobased fiber material derived from squid ring teeth protein using genetic sequencing tools, intended as an alternative to petroleum-based fibers for the textile industry. The company applies biomimetic design to create durable, more sustainable textile materials.
- Who founded Tandemrepeat?
- Tandemrepeat was founded by Melik Demirel.
- Who are Tandemrepeat's investors?
- Tandemrepeat's investors include Juniper.
- How much funding has Tandemrepeat raised?
- Tandemrepeat has disclosed $2.2M raised across 1 round.
- Where is Tandemrepeat headquartered?
- Tandemrepeat is headquartered in Philadelphia, US.